Technology Transfer

Before You Collaborate, You Should Partner with NCI TTC

By Karen Surabian, Thomas Stackhouse, and Jeffrey W. Thomas, Contributing Writers

As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations.

To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center (NCI TTC) can guide you through a tool box of agreements you may need for protecting your intellectual property (IP) and effectively managing your collaboration. 

Tags: 

Nineteen Patents Issued in 2012 for Inventions by Frederick Researchers

By Karen Surabian, Contributing Writer

Patents provide a period of exclusivity and are a way to exclude others from making, using, or selling an inventor’s novel technology. For the National Institutes of Health (NIH), patents are an incentive for an outside party to license, develop, and commercialize NIH technologies that will benefit public health, especially those that require substantial further development by an outside party, such as therapeutics and diagnostics.

Tags: 

CRADAs: They're Not Just for NCI Anymore

By Karen Surabian, Thomas Stackhouse, and Jeffrey Thomas, Contributing Writers, and Bruce Crise, Guest Writer

Advancing scientific discovery is increasingly dependent on diverse and innovative partnerships, and the Cooperative Research and Development Agreement (CRADA) is an essential tool for establishing partnerships. CRADAs allow a federal laboratory to enter into collaborative research and development (R&D) projects with outside parties (commercial or nonprofit).

Tags: 

Pages

Subscribe to RSS - Technology Transfer